Effect of a multidisciplinary in-patient rehabilitation program for patients with ankylosing spondylitis: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75685576

Enrollment

100

Registered

2006-05-25

Start date

2006-01-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing spondylitis (AS) Musculoskeletal Diseases Ankylosing spondylitis

Interventions

The study is a prospective, randomised, controlled (two arm) trial. The two groups are: 1. A three-week multidisciplinary in-patient rehabilitation program 2. Standard

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 65 years 2. AS according to the New York classification criteria 3. Ability to communicate in Norwegian

Exclusion criteria

Exclusion criteria: 1. Coronary heart disease 2. Surgery or rehabilitation last six months 3. Cognitive impairment or mental disease 4. Pregnancy 5. Change in medication last month 6. BASDAI score <40 mm

Design outcomes

Primary

Measure	Time frame
1. Physical function, measured by the Bath ankylosing spondylitis functional index (BASFI) 2. Pain, stiffness, fatigue and disease activity: Bath ankylosing spondylitis disease activity index (BASDAI)	—

Secondary

Measure	Time frame
1. Self-efficacy: the Arthritis Self-Efficacy Scale (ASES) 2. General health: the Short Form-36 and the BAS Patient Global Score (BAS-G)3. Joint mobility: BAS Metrology Index (BASMI) 4. Biological signs of inflammation: erythrocyte sedimentation rate and C-reactive protein 5. Activity and participation: the Canadian Occupational Performance Measure (COPM) 6. Sleep quality: the Pittsburgh Sleep Quality Index 7. Fatigue: BASDAI, SF-36 (vitality scale) and the Multidimensional Fatigue Inventory 8. Use of medications and health care resources	—

Measure

Time frame

1. Self-efficacy: the Arthritis Self-Efficacy Scale (ASES) 2. General health: the Short Form-36 and the BAS Patient Global Score (BAS-G)3. Joint mobility: BAS Metrology Index (BASMI) 4. Biological signs of inflammation: erythrocyte sedimentation rate and C-reactive protein 5. Activity and participation: the Canadian Occupational Performance Measure (COPM) 6. Sleep quality: the Pittsburgh Sleep Quality Index 7. Fatigue: BASDAI, SF-36 (vitality scale) and the Multidimensional Fatigue Inventory 8. Use of medications and health care resources

—

Countries

Norway

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026